AI in healthcare and life sciences: key considerations

Written By

ben woodfield module
Ben Woodfield

Senior Associate
UK

I am a senior associate in Bird & Bird's London-based Commercial Group. My practice principally involves advising clients on complex projects (including major public sector programmes and transformational outsourcings) and on a range of technology matters. More broadly, I advise on a variety of supply and services agreements across a number of sectors, with a particular focus on the Life Sciences & Healthcare and Defence sectors.

Digital technology is changing the way in which we receive healthcare. Healthcare providers are increasingly looking to adopt digital technologies such as Artificial Intelligence (AI) as the benefits become clear. AI is particularly attractive given its ability to analyse large quantities of complex data. The NHS’s commitment to AI is demonstrated through the NHS AI Lab, which brings together government, health and care providers, academics and technology companies with the aim of accelerating the safe adoption of AI in health and care.

AI provides a myriad of opportunities for healthcare and life sciences, but also a few key challenges to navigate and understand.

View the full article on digitalbusiness.law >

Latest insights

More Insights
Curiosity line pink background

Key Privacy Issues in Adtech

1 minute Nov 22 2024

Read More
featured image

Bird & Bird marks World Children’s Day by announcing its forthcoming Global Comparative Guide to Children in the Digital World

7 minutes Nov 20 2024

Read More
The European Commission Modern office buildings in Brussels, Belgium.

VAT in the Digital Age (“ViDA”): prepare your business with Bird & Bird – 10 key insights for success

Nov 15 2024

Read More